Selçuk Tıp Fakültesi Hastanesi
Konya, Turkey (Türkiye)
Location status: Recruiting
NCT Number: NCT05730088
Chronic obstructive pulmonary disease (COPD) is a progressive lung disease characterized by persistent airflow obstruction and chronic respiratory symptoms or alpha-1-antitrypsin deficiency in response to inhaled cigarette smoke or other irritants. The excessive morbidity and mortality associated with COPD acute exacerbations represent a significant public health problem that places a high burden on patients, their families and society. In frequent and severe exacerbations, patients may experience a decrease in quality of life, depression, and even death up to one year after hospitalization. Costs associated with COPD are more than $15.5 billion, and hospitalizations and repeated hospital admissions related to acute exacerbations alone account for 70% of all costs. For these reasons, efforts to reduce hospital admissions and hospitalizations associated with recurrent exacerbations are imperative to improve patient's quality of life and reduce the societal burden.
Interested in participating?
Request Info18 year and older
All sexes
Interventional
Not applicable
Konya, Turkey (Türkiye)
Location status: Recruiting
The patients in the intervention group will be called by the researcher within 3-7 days after discharge for the purpose of getting to know each other. The researcher will inform the participants/relatives about the purpose of the study and the procedures to be performed. The date and time for the next call will be given and the next phone call will be planned. The researcher will inform the patients/relatives about the materials sent. During the phone call, any questions the patient has about their illness, medications, or oxygen concentrator will be answered by the researcher. Then, the patient will be asked whether they have been to the hospital after being discharged and this self-reported information will be recorded on the prepared hospital application form. If they have applied to the hospital, the department(s) will be asked and noted. At the end of the phone call, the time and day of the next call will be planned with the patient/relatives. The second phone call will be made by the researcher within 3 months after discharge to the patients in the intervention group and the date and time of the phone call will be planned after the approval of the researcher and the patient/relatives and the call plan will be made. During the phone call, the researcher will first introduce himself/herself and briefly explain why the phone call is being made. During the phone call, any questions the patient may have about his/her illness, medications, or oxygen concentrator will be answered by the researcher. Then, after the patient is discharged, the patient's hospital application will be asked and the answers received based on self-reporting will be written on the hospital application form. If there is a hospital application, the department/departments will be asked and noted. 5 minutes of the phone call will include introductions and general topics about the illness, the second 5 minutes will answer any questions the patient/relatives may have, and the last 5 minutes will end with the researcher providing consultancy services on what needs to be done in the future. Care will be taken not to exceed 20 minutes. At the end of the call, the date and time of the last call will be determined by talking to the patient/relative. In the phone call in the third month, the mMRC dyspnea scale and the St George Respiratory Questionnaire (Quality of Life Scale) and Hospital Application Form interim measurements will be collected by a researcher outside the study.
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Health Education: While they are still in the hospital, a 30-minute individually planned education about their disease will be given to patients using the COPD patient education booklet. step 1. Smoking cessation, step 2. Vaccination, step 3. Correct drug use, step 4. Regular exercise, step 5. Healthy eating, step 6. Coping with stress, step 7 Coping with attacks, step 8. Includes regular oxygen therapy. Let's learn nhaverug treatments in coping with COPD, under the title of pulmonary rehabilitation (Respiratory Rehabilitation), methods of coping with shortness of breath, indoor air pollution and outdoor air pollution subheadings.
A group will be created through the WhatsApp application for participants in health education and visual and audio materials will be shared through this group every week. In the coming weeks, the researcher will provide consultancy services to those who have problems with the application.
Participants will be called every month by the researcher and asked if there are any hospital visits in that month, especially if they are chest disease visits.
Time frame: At the end of the 1st month.
Number of hospital admissions
Time frame: At the end of the 3st month.
Number of hospital admissions
Time frame: At the end of the 6st month.
Number of hospital admissions
Time frame: At the end of the 1st month.
0 points for no dyspnea (no respiratory distress when moving quickly on a flat surface or climbing a gentle slope);
As the score increases, the level of dyspnea also increases.
Time frame: At the end of the 3st month.
0 points for no dyspnea (no respiratory distress when moving quickly on a flat surface or climbing a gentle slope);
As the score increases, the level of dyspnea also increases.
Time frame: At the end of the 6st month.
0 points for no dyspnea (no respiratory distress when moving quickly on a flat surface or climbing a gentle slope);
As the score increases, the level of dyspnea also increases.
Time frame: At the end of the 1st month.
The total score that can be obtained from the scale is 0 min. - 100 max. The number zero indicates good health, and the number 100 indicates poor health. The scale is Likert type and the questions are in the form of "yes" and "no".
The symptoms section consists of 8 items and is scored in the range of 0-16 points.
The activity section consists of 16 items and is scored in the range of 0-32 points.
The effects of the disease section consists of 26 items and is scored in the range of 0-52 points.
Time frame: At the end of the 3st month.
The total score that can be obtained from the scale is 0 min. - 100 max. The number zero indicates good health, and the number 100 indicates poor health. The scale is Likert type and the questions are in the form of "yes" and "no".
The symptoms section consists of 8 items and is scored in the range of 0-16 points.
The activity section consists of 16 items and is scored in the range of 0-32 points.
The effects of the disease section consists of 26 items and is scored in the range of 0-52 points.
Time frame: At the end of the 6st month.
The total score that can be obtained from the scale is 0 min. - 100 max. The number zero indicates good health, and the number 100 indicates poor health. The scale is Likert type and the questions are in the form of "yes" and "no".
The symptoms section consists of 8 items and is scored in the range of 0-16 points.
The activity section consists of 16 items and is scored in the range of 0-32 points.
The effects of the disease section consists of 26 items and is scored in the range of 0-52 points.
Contact information is provided by the study sponsor or research team.
Necmettin Erbakan University
Other
The Effect of Post-Discharge Multiple Nursing Interventions on the Number of Hospital Admissions, Dyspnea Level, and Quality of Life in COPD Patients Receiving Home Oxygen Therapy: A Randomized Controlled Study
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT07177339
Chronic Disease, Disease Attributes
Doral, Florida, United States
View Trial DetailsNCT06755008
Chronic Disease, Disease Attributes
Montpellier, Hérault, France
View Trial DetailsNCT05704881
Chronic Disease, Disease Attributes
Grenoble, Isère, France
View Trial DetailsNCT05265299
Chronic Disease, Disease Attributes
Baltimore, Maryland, United States
View Trial Details